Long-term Follow-up of Depressive Disorders in Psychiatric Care

Recruiting Observational Study
Depression Psychiatric Diagnosis Personality Disorders Suicide, Attempted CYP2D6 Polymorphism Anhedonia
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
415 (estimated)
Sponsor
Region Skane · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The project investigates long-term prognosis and predictors of treatment outcomes for difficult-to-treat depression in patients in secondary psychiatric care. The current patient cohort was collected in 2012-2021 in the study "Pharmacogenetics in patients with depression with specific focus on difficult-to-treat depression, suicide attempt and CYP2D6". The cohort consists of 415 patients, examined…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: Participation in the study "Pharmacogenetics in depressive patients with specific focus on difficult-to-treat depression, suicide attempt and CYP2D6" Exclusion Criteria: Not wanting to participate in the follow-up study
Contacts

Marie Asp, MD, PhD

+46702731013

marie.asp@skane.se

CONTACT